Cargando…

Correction: Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010

Detalles Bibliográficos
Autores principales:	Rehal, Balvinder, Armstrong, April
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107338/ http://dx.doi.org/10.1371/annotation/6d5e99c5-bd8f-4cef-b77a-fbb795633da0

Ejemplares similares

Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010
por: Rehal, Balvinder, et al.
Publicado: (2011)

Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022)

Correction: Twenty-five-year trends in breastfeeding initiation: The effects of sociodemographic changes in Great Britain, 1985-2010
Publicado: (2019)

Correction: Profiling of Serum and Urinary MicroRNAs in Children with Atopic Dermatitis
Publicado: (2015)

Correction: Patch test results in paediatric patients with atopic dermatitis in Laos
por: Wootton, Catriona I., et al.
Publicado: (2020)

Quality of Life and Disease Severity Are Correlated in Patients with Atopic Dermatitis
por: Kim, Dong Ha, et al.
Publicado: (2012)

Author Correction: Automated severity scoring of atopic dermatitis patients by a deep neural network
por: Bang, Chul Hwan, et al.
Publicado: (2021)

Correction to: Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic Dermatitis
por: Wojciechowski, Jessica, et al.
Publicado: (2022)

Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD
por: Hall, Rebecca, et al.
Publicado: (2021)

Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis
por: Geng, Bob, et al.
Publicado: (2021)

Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2023)

Quality of life in infants with atopic dermatitis and their families
por: Djurović, Milena Ražnatović, et al.
Publicado: (2020)

Correction to: Content validity of a sleep numerical rating scale and a sleep diary in adults and adolescents with moderate-to-severe atopic dermatitis
por: Dias-Barbosa, Carla, et al.
Publicado: (2020)

Correction: Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic Dermatitis
por: Zhao, Yan, et al.
Publicado: (2016)

Lifelong Impact of Severe Atopic Dermatitis on Quality of Life: A Case Report
por: Bashyam, Arjun M., et al.
Publicado: (2021)

Effects of disease severity on sleep and quality of life in Taiwanese patients with atopic dermatitis
por: Ho, Pei-Yun, et al.
Publicado: (2022)

Challenges and Future Trends in Atopic Dermatitis
por: Gatmaitan, Julius Garcia, et al.
Publicado: (2023)

Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
por: Lee, Hae-Hyuk, et al.
Publicado: (2007)

341 Quality of Life in Pediatric Patients with Atopic Dermatitis
por: Campos, Xiomara Lopez
Publicado: (2012)

Quality of Life and Psychological Impact in Patients with Atopic Dermatitis
por: Talamonti, Marina, et al.
Publicado: (2021)

Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea
por: Son, Sang Wook, et al.
Publicado: (2022)

Patient-reported outcome (PRO) instruments for disease severity and quality of life in patients with atopic dermatitis: a systematic review of English and Chinese literature
por: Li, Aihua, et al.
Publicado: (2022)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis
por: Yosipovitch, Gil, et al.
Publicado: (2021)

New and emerging trends in the treatment of atopic dermatitis
por: Gelbard, Christina M, et al.
Publicado: (2008)

Quality of life measures in Italian children with atopic dermatitis and their families
por: Monti, Fiorella, et al.
Publicado: (2011)

Family quality of life among families of children with atopic dermatitis
por: Jang, Hae Ji, et al.
Publicado: (2016)

IMPACT OF ATOPIC DERMATITIS ON THE QUALITY OF LIFE OF PEDIATRIC PATIENTS AND THEIR GUARDIANS
por: Campos, Amanda Letícia Bezerra, et al.
Publicado: (2017)

Does age influence the quality of life in children with atopic dermatitis?
por: Ražnatović Đurović, Milena, et al.
Publicado: (2019)

The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh
por: Nagata, Abir, et al.
Publicado: (2021)

Educational intervention and atopic dermatitis: impact on quality of life and treatment
por: Muzzolon, Mariana, et al.
Publicado: (2021)

Counting the Burden: Atopic Dermatitis and Health-related Quality of Life
por: ALI, Faraz, et al.
Publicado: (2020)

Author Correction: The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins
por: Brunner, Patrick M., et al.
Publicado: (2018)

Correction: Genome-Wide Analysis in German Shepherd Dogs Reveals Association of a Locus on CFA 27 with Atopic Dermatitis
por: Tengvall, Katarina, et al.
Publicado: (2013)

Correction: Genome-Wide Analysis in German Shepherd Dogs Reveals Association of a Locus on CFA 27 with Atopic Dermatitis
por: Tengvall, Katarina, et al.
Publicado: (2015)

Prevalence and Trends in Obesity among China’s Children and Adolescents, 1985–2010
por: Sun, Hongpeng, et al.
Publicado: (2014)

Atopic Dermatitis Severity, Patient Perception of the Disease, and Personality Characteristics: How Are They Related to Quality of Life?
por: Lugović-Mihić, Liborija, et al.
Publicado: (2021)

Erratum: Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea
por: Son, Sang Wook, et al.
Publicado: (2023)

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis
por: Fahrbach, Kyle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bd2iqejehhmi558sr2ts5d1m9f